Opposite Prognostic Impact of Single PTEN-loss and PIK3CA Mutations in Early High-risk Breast Cancer

Background/Aim: PTEN-loss and PIK3CA mutations have been addressed as markers of PI3K activation in breast cancer. We evaluated these markers in early high-risk breast cancer (EBC) focusing on PTEN immunohistochemistry (IHC) issues, particularly in HER2-positive disease. Materials and Methods: We ex...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Genomics Proteomics
Egile Nagusiak: LAZARIDIS, GEORGIOS, KOTOULA, VASSILIKI, VRETTOU, ELENI, KOSTOPOULOS, IOANNIS, MANOUSOU, KYRIAKI, PAPADOPOULOU, KYRIAKI, GIANNOULATOU, ELENI, BOBOS, MATTHEOS, SOTIROPOULOU, MARIA, PENTHEROUDAKIS, GEORGE, EFSTRATIOU, IOANNIS, PAPOUDOU-BAI, ALEXANDRA, PSYRRI, AMANDA, CHRISTODOULOU, CHRISTOS, GOGAS, HELEN, KOUTRAS, ANGELOS, TIMOTHEADOU, ELENI, PECTASIDES, DIMITRIOS, ZAGOURI, FLORA, FOUNTZILAS, GEORGE
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: International Institute of Anticancer Research 2019
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6542648/
https://ncbi.nlm.nih.gov/pubmed/31018950
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/cgp.20125
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak